Breast Cancer Genetic and Genomic Testing

Understand how polygenic risk scores go beyond BRCA testing to assess your breast cancer risk. Learn what these genetic tools can and cannot tell you today.

Confused by breast cancer genomic testing? Learn the differences between Oncotype DX and MammaPrint to understand how these scores guide your chemotherapy decisions.

Don't let costs block your health. Learn about insurance coverage, Medicare, financial assistance, and how to access affordable BRCA testing for your care.

Learn how to interpret your breast cancer recurrence risk score. Discover the difference between genomic tests and how these results guide your treatment path.

Understand your BRCA status beyond risk assessment. Learn about testing costs, interpreting results, and how genetics shape personalized cancer treatment plans.

When you’re diagnosed with breast cancer, one of the biggest questions is often: “What is the risk that my cancer could come back?” The answer is not always straightforward and two breast cancers that appear very similar based on size, stage, or even subtype can behave very differently over time. This is where genomic recurrence […]

Many people are surprised to find out that only a small number of breast cancer cases are caused by inherited (or germline) genetic mutations. Even if you have multiple family members who have received a breast cancer diagnosis this does not guarantee there is a genetic mutation. Family history is a piece of the risk […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. We recently hosted Fred Hutch Cancer Center’s Dr. Sara A. Hurvitz for a helpful discussion on the various types of breast assays and tools used to […]

Dr. Sara Hurvitz, a medical oncologist and clinical research leader at Fred Hutch, recently joined Outcomes4Me for an informative webinar relevant for all patients navigating their breast cancer care. Read on for a recap of the important advancements in breast cancer testing that all patients should know. Watch the full webinar The following questions and […]

Knowing your ESR1 status provides your care team with invaluable insights that can help optimize your treatment outcomes. To help facilitate conversations with your care team surrounding ESR1 mutations and testing, we’ve transcribed a few key points from our discussion with Dr. Anne O’Dea. Dr. O’Dea is the Medical Director of Breast Cancer Survivorship and […]

In our webinar titled “Unlocking Precision Care: Genomic Testing for Breast Cancer Management,” medical oncologist Dr. Tiffany Avery explores how different tests can guide personalized treatment plans for breast cancer patients. You can watch the full webinar below. Watch the full replay here We’ve transcribed some of the key takeaways from this discussion to help […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.